Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Propofol with versus without ketamine during ECT in adults with mood disorders
IRCT20231217060435N1Phase 3Completed
- Sponsor
- Shahid Beheshti University of Medical Sciences
- Start
- Apr 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial in major depressive disorder (MDD), bipolar disorder (BD) and affective disorder comparing Propofol + ketamine with Propofol alone (2 arms). Primary endpoint: Montreal Cognitive Assessment score. Started Apr 2024; status: completed.
02
Drugs
propofolketamine
03
Conditions
major depressive disorder (MDD)bipolar disorder (BD)affective disorder
Beyond the preview
Go deeper on IRCT20231217060435N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20231217060435N1.